SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-17-000560
Filing Date
2017-02-13
Accepted
2017-02-13 17:01:28
Documents
76
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nvls-20161231x10k.htm 10-K 3023189
2 EX-10.10 nvls-20161231ex10103c720.htm EX-10.10 45313
3 EX-10.14 nvls-20161231ex1014eda14.htm EX-10.14 25657
4 EX-10.15 nvls-20161231ex10157b9f3.htm EX-10.15 15264
5 EX-10.17 nvls-20161231ex101750a3d.htm EX-10.17 28385
6 EX-10.18 nvls-20161231ex10180e577.htm EX-10.18 15272
7 EX-10.20 nvls-20161231ex10200976d.htm EX-10.20 18506
8 EX-10.21 nvls-20161231ex102155e74.htm EX-10.21 44931
9 EX-10.9 nvls-20161231ex10947ec03.htm EX-10.9 18699
10 EX-23.1 nvls-20161231ex2314bfc3a.htm EX-23.1 7257
11 EX-31.1 nvls-20161231ex31181bbd4.htm EX-31.1 19471
12 EX-32.1 nvls-20161231ex32131d3bb.htm EX-32.1 6380
13 GRAPHIC nvls20161231x10k001.jpg GRAPHIC 79214
  Complete submission text file 0001558370-17-000560.txt   8801973

Data Files

Seq Description Document Type Size
14 EX-101.INS nvls-20161231.xml EX-101.INS 1667422
15 EX-101.SCH nvls-20161231.xsd EX-101.SCH 39631
16 EX-101.CAL nvls-20161231_cal.xml EX-101.CAL 44118
17 EX-101.DEF nvls-20161231_def.xml EX-101.DEF 194644
18 EX-101.LAB nvls-20161231_lab.xml EX-101.LAB 457157
19 EX-101.PRE nvls-20161231_pre.xml EX-101.PRE 349946
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37449 | Film No.: 17600262
SIC: 2834 Pharmaceutical Preparations